Bergenstal Richard M, Gavin James R
International Diabetes Center, Minneapolis, Minnesota 55416, USA.
Am J Med. 2005 Sep;118(Suppl 9A):1S-6S. doi: 10.1016/j.amjmed.2005.07.055.
Self-monitoring of blood glucose (SMBG) is an underutilized but integral part of disease management for patients with both type 1 and type 2 diabetes. Guidelines on the recommended frequency and timing of SMBG vary among international diabetes associations, and patients are often unaware of actions they should take in response to SMBG. results. In response to this, a global consensus conference of recognized diabetes experts convened to clarify the role of SMBG as a tool to help optimize glycemic control (e.g., complementing information provided by hemoglobin A1c, detecting postprandial excursions, identifying glucose patterns, and providing patients feedback on lifestyle and medications) while minimizing hypoglycemia and maintaining quality of life. The consensus panel also sought to reinforce the importance of appropriate and systematic patient and provider response to the collected SMBG data. A set of 16 consensus statements was approved by the panel. This article presents the 16 statements together with some brief rationale for their inclusion.
自我血糖监测（SMBG）是1型和2型糖尿病患者疾病管理中未得到充分利用但不可或缺的一部分。国际糖尿病协会对于SMBG的推荐频率和时间安排的指导方针各不相同，患者往往不知道针对SMBG结果应采取的行动。对此，知名糖尿病专家召开了一次全球共识会议，以阐明SMBG作为一种有助于优化血糖控制的工具的作用（例如，补充糖化血红蛋白提供的信息、检测餐后血糖波动、识别血糖模式以及为患者提供关于生活方式和药物治疗的反馈），同时将低血糖风险降至最低并维持生活质量。共识小组还试图强化患者和医疗服务提供者对所收集的SMBG数据做出适当且系统反应的重要性。该小组批准了一组16条共识声明。本文呈现了这16条声明以及纳入这些声明的一些简要理由。
